HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the... |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Rocuronium bromide (NDC 0409-9558-05 and 0409-9558-10) (rocuronium bromide)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Rocuronium bromide (NDC 0409-9558-05 and 0409-9558-10) Quick Finder
1 INDICATIONS AND USAGE
Rocuronium bromide injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal...
2 DOSAGE AND ADMINISTRATION
2.1 Important Dosing and Administration Information
Rocuronium bromide injection is for intravenous use only. ...
3 DOSAGE FORMS AND STRENGTHS
Rocuronium bromide is available as
- •
- 5 mL multiple dose vials containing 50 mg rocuronium bromide injection (10 mg/mL)
- •
- 10 mL multiple dose vials containing...
4 CONTRAINDICATIONS
Rocuronium bromide is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [...
5 WARNINGS AND PRECAUTIONS
5.1 Appropriate Administration and Monitoring
Rocuronium bromide should be administered in carefully adjusted...
6 ADVERSE REACTIONS
In clinical trials, the most common adverse reactions (2%) are transient hypotension and hypertension.
The following adverse reactions are described, or described in greater detail, in other...
7 DRUG INTERACTIONS
7.1 Antibiotics
Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as rocuronium bromide include certain...
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Developmental toxicology studies have been performed with rocuronium bromide in pregnant, conscious, nonventilated rabbits...
10 OVERDOSAGE
Overdosage with neuromuscular blocking agents may result in neuromuscular block beyond the time needed for surgery and anesthesia. The primary treatment is maintenance of a patent airway, controlled ventilation...
11 DESCRIPTION
Rocuronium bromide injection is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on dose and intermediate duration. Rocuronium bromide is chemically designated as 1-[...
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
Rocuronium bromide is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on...
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
Studies in animals have not been performed with rocuronium bromide to evaluate...
14 CLINICAL STUDIES
In US clinical studies, a total of 1137 patients received rocuronium bromide, including 176 pediatric, 140 geriatric, 55 obstetric, and 766 other adults. Most patients (90%) were ASA physical status I or...
16 HOW SUPPLIED/STORAGE AND HANDLING
Rocuronium bromide is available in the following:
17 PATIENT COUNSELING INFORMATION
Obtain information about your patient's medical history, current medications, any history of hypersensitivity to rocuronium bromide or other neuromuscular blocking agents. If applicable,...
To interact with the Medical Information Digital Assistant click here.
Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.
(800)-332-1088.